Zentalis Pharmaceuticals IncNASDAQ:ZNTL
- LAST PRICE3.6900
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots3.7000/ 2
- Ask / Lots3.7100/ 9
- Open / Previous Close--- / 3.6900
- Day Range---
- 52 Week Range
- Volume1,135
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | ZNTL |
|---|---|---|
| 09:32 ET | 4423 | 3.82 |
| 09:34 ET | 4853 | 3.8 |
| 09:36 ET | 1100 | 3.81 |
| 09:38 ET | 2100 | 3.81 |
| 09:39 ET | 6560 | 3.8 |
| 09:41 ET | 1837 | 3.8 |
| 09:43 ET | 8074 | 3.77 |
| 09:45 ET | 3877 | 3.785 |
| 09:48 ET | 2968 | 3.79 |
| 09:50 ET | 2636 | 3.78 |
| 09:52 ET | 4000 | 3.78 |
| 09:54 ET | 4500 | 3.775 |
| 09:56 ET | 1160 | 3.77 |
| 09:57 ET | 1773 | 3.755 |
| 09:59 ET | 3042 | 3.7806 |
| 10:01 ET | 500 | 3.78 |
| 10:03 ET | 944 | 3.76 |
| 10:06 ET | 500 | 3.76 |
| 10:08 ET | 1129 | 3.755 |
| 10:10 ET | 6135 | 3.74 |
| 10:12 ET | 1382 | 3.7406 |
| 10:14 ET | 3982 | 3.75 |
| 10:15 ET | 3400 | 3.74 |
| 10:17 ET | 2900 | 3.74 |
| 10:19 ET | 1710 | 3.7398 |
| 10:21 ET | 9930 | 3.74 |
| 10:24 ET | 11101 | 3.78 |
| 10:26 ET | 366 | 3.77 |
| 10:28 ET | 400 | 3.77 |
| 10:30 ET | 2915 | 3.76 |
| 10:32 ET | 400 | 3.76 |
| 10:33 ET | 1744 | 3.765 |
| 10:35 ET | 1262 | 3.77 |
| 10:37 ET | 1853 | 3.76 |
| 10:39 ET | 100 | 3.77 |
| 10:42 ET | 2156 | 3.76 |
| 10:44 ET | 9036 | 3.74 |
| 10:46 ET | 1965 | 3.74 |
| 10:48 ET | 1732 | 3.755 |
| 10:50 ET | 3035 | 3.75 |
| 10:51 ET | 851 | 3.75 |
| 10:53 ET | 8525 | 3.74 |
| 10:55 ET | 5863 | 3.73 |
| 10:57 ET | 4599 | 3.72 |
| 11:00 ET | 2985 | 3.72 |
| 11:02 ET | 9107 | 3.67 |
| 11:04 ET | 5699 | 3.6881 |
| 11:06 ET | 9549 | 3.675 |
| 11:08 ET | 4500 | 3.68 |
| 11:09 ET | 22884 | 3.705 |
| 11:11 ET | 500 | 3.7 |
| 11:13 ET | 1624 | 3.7 |
| 11:15 ET | 1162 | 3.7001 |
| 11:18 ET | 2600 | 3.715 |
| 11:20 ET | 3370 | 3.725 |
| 11:22 ET | 200 | 3.725 |
| 11:24 ET | 1872 | 3.71 |
| 11:26 ET | 1256 | 3.72 |
| 11:27 ET | 700 | 3.72 |
| 11:29 ET | 3354 | 3.72 |
| 11:31 ET | 2750 | 3.72 |
| 11:33 ET | 1793 | 3.72 |
| 11:36 ET | 100 | 3.72 |
| 11:38 ET | 1665 | 3.71 |
| 11:40 ET | 3255 | 3.725 |
| 11:42 ET | 1200 | 3.72 |
| 11:44 ET | 10598 | 3.72 |
| 11:45 ET | 3549 | 3.745 |
| 11:47 ET | 499 | 3.745 |
| 11:49 ET | 1000 | 3.74 |
| 11:51 ET | 500 | 3.74 |
| 11:54 ET | 1346 | 3.75 |
| 11:56 ET | 3514 | 3.75 |
| 11:58 ET | 856 | 3.755 |
| 12:00 ET | 300 | 3.75 |
| 12:02 ET | 724 | 3.75 |
| 12:03 ET | 2233 | 3.74 |
| 12:05 ET | 1178 | 3.75 |
| 12:07 ET | 6859 | 3.735 |
| 12:09 ET | 1130 | 3.745 |
| 12:12 ET | 273 | 3.745 |
| 12:14 ET | 449 | 3.745 |
| 12:16 ET | 5887 | 3.73 |
| 12:18 ET | 525 | 3.73 |
| 12:20 ET | 2970 | 3.73 |
| 12:21 ET | 1733 | 3.735 |
| 12:23 ET | 300 | 3.73 |
| 12:25 ET | 1953 | 3.72 |
| 12:27 ET | 15072 | 3.71 |
| 12:30 ET | 1000 | 3.71 |
| 12:32 ET | 1000 | 3.715 |
| 12:34 ET | 4802 | 3.72 |
| 12:36 ET | 1635 | 3.72 |
| 12:38 ET | 400 | 3.72 |
| 12:39 ET | 200 | 3.725 |
| 12:41 ET | 1318 | 3.725 |
| 12:43 ET | 2135 | 3.725 |
| 12:45 ET | 2141 | 3.735 |
| 12:48 ET | 200 | 3.735 |
| 12:50 ET | 100 | 3.73 |
| 12:52 ET | 3444 | 3.72 |
| 12:54 ET | 2110 | 3.725 |
| 12:57 ET | 3859 | 3.72 |
| 12:59 ET | 3908 | 3.72 |
| 01:01 ET | 300 | 3.715 |
| 01:03 ET | 1208 | 3.695 |
| 01:06 ET | 1680 | 3.6909 |
| 01:08 ET | 100 | 3.695 |
| 01:10 ET | 100 | 3.7 |
| 01:12 ET | 4635 | 3.695 |
| 01:14 ET | 3135 | 3.7 |
| 01:15 ET | 300 | 3.705 |
| 01:17 ET | 888 | 3.705 |
| 01:19 ET | 100 | 3.7 |
| 01:21 ET | 5428 | 3.69 |
| 01:24 ET | 200 | 3.695 |
| 01:26 ET | 5570 | 3.715 |
| 01:28 ET | 1461 | 3.7 |
| 01:30 ET | 385 | 3.7 |
| 01:32 ET | 400 | 3.705 |
| 01:33 ET | 2135 | 3.71 |
| 01:35 ET | 100 | 3.715 |
| 01:37 ET | 19285 | 3.68 |
| 01:39 ET | 1782 | 3.675 |
| 01:42 ET | 2035 | 3.68 |
| 01:46 ET | 1570 | 3.675 |
| 01:48 ET | 3340 | 3.675 |
| 01:50 ET | 2836 | 3.6888 |
| 01:51 ET | 1166 | 3.67 |
| 01:53 ET | 1239 | 3.68 |
| 01:55 ET | 500 | 3.675 |
| 01:57 ET | 1323 | 3.67 |
| 02:00 ET | 3200 | 3.675 |
| 02:02 ET | 200 | 3.67 |
| 02:04 ET | 1200 | 3.68 |
| 02:06 ET | 2063 | 3.67 |
| 02:08 ET | 2871 | 3.67 |
| 02:09 ET | 200 | 3.67 |
| 02:11 ET | 1310 | 3.67 |
| 02:13 ET | 860 | 3.675 |
| 02:15 ET | 2491 | 3.68 |
| 02:18 ET | 500 | 3.685 |
| 02:20 ET | 400 | 3.68 |
| 02:22 ET | 4938 | 3.71 |
| 02:24 ET | 300 | 3.71 |
| 02:26 ET | 331 | 3.709 |
| 02:27 ET | 639 | 3.7099 |
| 02:31 ET | 713 | 3.705 |
| 02:33 ET | 300 | 3.7 |
| 02:36 ET | 1400 | 3.695 |
| 02:38 ET | 575 | 3.695 |
| 02:40 ET | 5240 | 3.701 |
| 02:42 ET | 1175 | 3.705 |
| 02:44 ET | 369 | 3.7 |
| 02:45 ET | 1557 | 3.695 |
| 02:47 ET | 859 | 3.7 |
| 02:49 ET | 1400 | 3.695 |
| 02:51 ET | 2867 | 3.685 |
| 02:54 ET | 2235 | 3.695 |
| 02:56 ET | 1647 | 3.69 |
| 02:58 ET | 2800 | 3.69 |
| 03:00 ET | 694 | 3.69 |
| 03:02 ET | 5617 | 3.695 |
| 03:03 ET | 3193 | 3.695 |
| 03:05 ET | 646 | 3.695 |
| 03:07 ET | 13901 | 3.68 |
| 03:09 ET | 5932 | 3.69 |
| 03:12 ET | 696 | 3.695 |
| 03:14 ET | 4588 | 3.695 |
| 03:16 ET | 1548 | 3.7 |
| 03:18 ET | 605 | 3.7 |
| 03:20 ET | 4692 | 3.685 |
| 03:21 ET | 700 | 3.68 |
| 03:23 ET | 2571 | 3.675 |
| 03:25 ET | 1416 | 3.675 |
| 03:27 ET | 6268 | 3.67 |
| 03:30 ET | 9859 | 3.675 |
| 03:32 ET | 8433 | 3.67 |
| 03:34 ET | 4743 | 3.675 |
| 03:36 ET | 4050 | 3.685 |
| 03:38 ET | 2832 | 3.67 |
| 03:39 ET | 5794 | 3.6812 |
| 03:41 ET | 10985 | 3.7 |
| 03:43 ET | 3589 | 3.685 |
| 03:45 ET | 7456 | 3.69 |
| 03:48 ET | 3609 | 3.68 |
| 03:50 ET | 11397 | 3.67 |
| 03:52 ET | 23281 | 3.665 |
| 03:54 ET | 13346 | 3.655 |
| 03:56 ET | 28517 | 3.645 |
| 03:57 ET | 42688 | 3.685 |
| 03:59 ET | 269955 | 3.69 |
Sep 16, 2024
Kuehn Law Encourages Investors of Zentalis Pharmaceuticals, Inc. to Contact Law Firm, from 9:38PM ET on Monday Sep 16, 2024 by Dow Jones
9:38PM ET on Monday Sep 16, 2024 by Dow JonesDJ Zentalis Pharmaceuticals Price Target Maintained With a $20.00/Share by Oppenheimer, from 2:03PM ET on Monday Sep 16, 2024 by Dow Jones
2:03PM ET on Monday Sep 16, 2024 by Dow JonesDJ Zentalis Shares Rise After U.S. FDA Lifts Hold on Azenosertib Studies, from 7:37AM ET on Monday Sep 16, 2024 by Dow Jones
7:37AM ET on Monday Sep 16, 2024 by Dow JonesZentalis Pharmaceuticals Announces FDA Has Lifted Partial Clinical Hold on Azenosertib Studies, from 7:00AM ET on Monday Sep 16, 2024 by Dow Jones
7:00AM ET on Monday Sep 16, 2024 by Dow Jones
Sep 9, 2024
Zentalis Pharmaceuticals to Present Preclinical Azenosertib Data at ESMO 2024, from 7:00AM ET on Monday Sep 09, 2024 by Dow Jones
7:00AM ET on Monday Sep 09, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Zentalis Pharmaceuticals Inc | 262.4M | -1.3x | --- |
Corbus Pharmaceuticals Holdings Inc | 258.8M | -3.7x | --- |
Rezolute Inc | 270.2M | -3.7x | --- |
Zura Bio Ltd | 253.2M | -8.0x | --- |
ESSA Pharma Inc | 275.5M | -9.9x | --- |
Black Diamond Therapeutics Inc | 249.2M | -2.9x | --- |
Company Information
Zentalis Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on discovering and developing small molecule therapeutics targeting fundamental biological pathways of cancers. The Company’s lead product candidate includes azenosertib (ZN-c3), which is a WEE1 inhibitor for advanced solid tumors and hematological malignancies. The Company is also developing a BCL-2 inhibitor, ZN-d5, for hematological malignancies and related disorders. ZN-d5 is being evaluated in combination with azenosertib in a Phase I/II dose escalation clinical trial in patients with R/R acute myeloid leukemia (AML) (ZN-d5-004C). The Company is also advancing its research on protein degraders and other undisclosed targets using its Integrated Discovery Engine.
Contact Information
- Headquarters
- 10275 Science Center Drive, Suite 200SAN DIEGO, CA, United States 92121
- Phone
- 858-263-4333
- Fax
- 302-655-5049
Executives
- Independent Chairman of the Board
- David Johnson
- President, Interim Chief Financial Officer, Interim Treasurer, Executive Director
- Cam Gallagher
- President, Chief Executive Officer, Director
- Kimberly Blackwell
- Chief Scientific Officer
- Mark Lackner,
- Chief Medical Officer
- Diana Hausman
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $262.4M |
|---|---|
Revenue (TTM) | $40.6M |
Shares Outstanding | 71.1M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.70 |
EPS | $-2.75 |
Book Value | $6.18 |
P/E Ratio | -1.3x |
Price/Sales (TTM) | 6.5 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -543.77% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
